Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
advanced breast cancer
.
Show all posts
Showing posts with label
advanced breast cancer
.
Show all posts
Friday, August 14, 2026
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
›
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) acceptance of ...
Monday, September 21, 2015
PALOMA3 supports palbociclib use in advanced breast cancer
›
In continuation of my update on palbociclib ... Advanced breast cancer patients who have failed prior endocrine treatment may rece...
›
Home
View web version
